Insurtech Startup CXA Raises US$ 25 Million  — Eyes Expansion in Asia-Pacific

Insurtech Startup CXA Raises US$ 25 Million — Eyes Expansion in Asia-Pacific

by March 14, 2019
  •  
  • 1.5K
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
    1.5K
    Shares

CXA Group, a one-stop, predictive and data intelligence platform for better health, wealth and wellness choices, announced today that it has raised US$25 million in its latest round of funding.

CXA’s new group of strategic investors include HSBC, Singtel Innov8, Telkom Indonesia MDI Ventures, Sumitomo Corporation Equity Asia, Muang Thai Fuchsia Ventures, Humanica and Heritas Venture Fund, underscoring the company’s aim to be the leading health ecosystem platform addressing escalating healthcare costs across the region.

With chronic diseases hitting people in Asia earlier than in the West and healthcare costs escalating , the company found that the antiquated pen-and-paper, one-size-fits-all approach to managing these costs was systemically wrong. This situation, if left unaddressed, would only get worse and become economically unsustainable over time.

The company has introduced a self-service platform that allows employers to give their employees access to an ever-widening range of health, wealth and wellness offerings, personalised based on the individual’s health and life-stage data.

Employees can purchase offerings by drawing down on existing insurance policies provided by their employers and using funds that are then released into the platform’s eWallet to make transactions cashless, fast and easy.

Through the aggregation, anonymisation and analysis of digitised health and life-stage data, CXA helps employers get to the root cause of their workforces’ health issues and design specific interventions – such as corporate wellness and disease management initiatives – that will have the greatest impact on cost and health improvement, for reductions in tomorrow’s chronic disease and healthcare spend, today.

Headquartered in Singapore, CXA achieved revenue growth of 65 percent in 2018 and is expected to double that in 2019. This latest funding round follows US$33 million in total funding from Series A and B in 2015 and 2017 respectively. Other investors in CXA include B Capital Group, Openspace Ventures, Government-linked strategic investor EDBI, BioVeda Capital, FengHe Asia, Philips and RGAx.

Print Friendly, PDF & Email
  •  
  • 1.5K
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
    1.5K
    Shares

1 Comment so far

Jump into a conversation

<